tiprankstipranks
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
India Market
AKUMS
Akums Drugs and Pharmaceuticals Limited
RESEARCH TOOLSreports

Akums Drugs and Pharmaceuticals Limited (AKUMS) Income Statement

4 Followers

Akums Drugs and Pharmaceuticals Limited Income Statement

Last quarter (Q4 2024), Akums Drugs and Pharmaceuticals Limited's total revenue was ₹10.08B, a decrease of -0.89% from previous quarter. In Q4, Akums Drugs and Pharmaceuticals Limited's net income was ₹1.48B. See Akums Drugs and Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 40.71B₹ 40.20B₹ 34.75B₹ 36.47B
Gross Profit
₹ 16.05B₹ 14.37B₹ 11.67B₹ 12.69B
Operating Expenses
₹ 12.95B₹ 10.78B₹ 9.76B₹ 9.47B
Depreciation and Amortization
₹ 1.53B₹ 1.26B₹ 1.13B₹ 946.79M
EBITDA
₹ 5.29B₹ 1.31B₹ 3.09B₹ -821.80M
Operating Income
₹ 3.11B₹ 3.60B₹ 1.91B₹ 3.22B
Other Income/Expenses
₹ 346.02M₹ -4.05B₹ -410.17M₹ -5.15B
Pretax Income
₹ 3.45B₹ -452.78M₹ 1.50B₹ -1.93B
Net Income
₹ 3.38B₹ -40.35M₹ 948.55M₹ -2.53B
Per Share Metrics
Basic EPS
₹ 22.60₹ -0.28₹ 6.03₹ -16.04
Diluted EPS
₹ 22.60₹ -0.28₹ 6.03₹ -16.04
Weighted Average Shares Outstanding
 149.61M 144.11M 157.39M 157.39M
Weighted Average Shares Outstanding (Diluted)
 149.61M 157.39M 157.39M 157.39M
Currency in INR

Akums Drugs and Pharmaceuticals Limited Earnings and Revenue History